Loading insider details...
Beta
Latest Form 4 (Sep 8, 2026): Exercise/Conversion of 2,500 CTNM shares, $2.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 2,500 | $2.5K |
| Aug 3, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 2,500 | $2.5K |
| Jul 8, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 2,500 | $2.5K |
| Jul 1, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 7,500 | $7.6K |
| Jun 12, 2026 | KIORA PHARMACEUTICALS INC (KPRX) | Grant/Award | 25,000 | n/a |
| Feb 26, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 4,400 | $5.5K |
| Feb 13, 2026 | Contineum Therapeutics, Inc. (CTNM) | Exercise/Conversion | 400 | $504.00 |
| Jan 30, 2026 | Contineum Therapeutics, Inc. (CTNM) | Grant/Award | 445,000 | n/a |
| Apr 2, 2025 | KIORA PHARMACEUTICALS INC (KPRX) | Grant/Award | 20,000 | n/a |
| Jan 31, 2025 | Contineum Therapeutics, Inc. (CTNM) | Grant/Award | 300,000 | n/a |